BioLife Solutions Announces COO to Retire and Join Board of Directors

BOTHELL, Wash., Oct. 3, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy ("CGT") and broader biopharma markets, today announced changes to its Board of Directors and executive management team, all to be effective as of January 3, 2023.